0001213900-17-009333.txt : 20170831 0001213900-17-009333.hdr.sgml : 20170831 20170831161909 ACCESSION NUMBER: 0001213900-17-009333 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170831 DATE AS OF CHANGE: 20170831 EFFECTIVENESS DATE: 20170831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADial Pharmaceuticals, L.L.C. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 800667150 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293906 FILM NUMBER: 171063584 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADial Pharmaceuticals, L.L.C. 1180 SEMINOLE TRAIL, SUITE 495 CHARLOTTESVILLE VA VIRGINIA 22902 434-422-9800 VIRGINIA None Adial Pharmaceuticals, L.L.C. Limited Liability Company true William B. Stilley, III 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer Director Joseph M. Truluck 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Executive Officer James K. Anderson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Robertson H. Gilliland 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Bankole A. Johnson 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director James W. Newman, Jr. 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Kevin Schuyler, CFA 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Tony Goodman 1180 Seminole Trail, Suite 495 Charlottesville VA VIRGINIA 22901 Director Pharmaceuticals Decline to Disclose 06b false 2017-06-11 false true true Class B Units false 0 40000 40000 0 false 2 0 0 0 true *Proceeds may be used to pay overhead and other corporate expenses which could include salaries false ADial Pharmaceuticals, L.L.C. /s/ William B. Stilley, III William B. Stilley, III Chief Executive Officer 2017-08-30